Stentys S.A.S. | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
31,872.50
18,607.00
10,655.00
16,988.00
8,794.00
9,878
Total Accounts Receivable
2,666.00
2,897.00
3,215.00
3,472.00
4,825.00
5,598
Inventories
1,633.90
1,562.00
4,108.00
2,455.00
2,220.00
2,711
Other Current Assets
336.90
395.00
237.00
88.00
90.00
77
Total Current Assets
36,509.20
23,461.00
18,215.00
23,003.00
15,929.00
18,264
Net Property, Plant & Equipment
79.50
92.00
61.00
102.00
98.00
240
Total Investments and Advances
-
153.00
573.00
419.00
-
-
Long-Term Note Receivable
-
-
-
-
248.00
270
Intangible Assets
3,354.60
4,433.00
3,674.00
2,441.00
1,633.00
5,980
Other Assets
157.00
-
111.00
100.00
102.00
93
Total Assets
40,100.30
28,139.00
22,634.00
26,065.00
18,010.00
25,700
ST Debt & Current Portion LT Debt
440.00
-
-
120.00
840.00
Accounts Payable
3,024.90
2,120.00
2,791.00
3,208.00
1,550.00
Income Tax Payable
70.40
493.00
272.00
225.00
510.00
Other Current Liabilities
980.80
3,367.00
3,081.00
3,628.00
2,740.00
Total Current Liabilities
4,516.10
5,980.00
6,144.00
7,181.00
5,640.00
Long-Term Debt
856.90
946.00
998.00
887.00
167.00
Provision for Risks & Charges
51.20
1,488.00
925.00
105.00
45.00
Total Liabilities
5,424.20
8,414.00
8,067.00
8,173.00
5,852.00
Common Equity (Total)
34,676.10
19,725.00
14,567.00
17,892.00
12,158.00
Total Shareholders' Equity
34,676.10
19,725.00
14,567.00
17,892.00
12,158.00
Total Equity
34,676.10
19,725.00
14,567.00
17,892.00
12,158.00
Liabilities & Shareholders' Equity
40,100.30
28,139.00
22,634.00
26,065.00
18,010.00

About Stentys

View Profile
Address
18, rue d' Hauteville
Paris Ile-de-France 75010
France
Employees -
Website http://www.stentys.com
Updated 07/08/2019
Stentys SA engages in the design, development and marketing of self-expanding stents used in treating cardiovascular diseases. It provides innovative solutions to the interventional cardiologist to treat patients with acute myocardial infarction and other complex coronary disease. The company's products include xpositions, mistent, stentys btk, stentys ac, ses stent and stentys stent.